PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24E25N0245Pre-trial testing for alzheimer's DRUG — Bioivt, LLC

Bioivt, LLC holds $814K across 24 federal awards, concentrated at Department of Health and Human Services (HHS). Recompete timing centers on the Sep 27, 2026 PoP end — agencies typically plan 12–18 months ahead.

Rpo East (36C24E)

Awarding office

Bioivt, LLC

Recipient

Sep 27, 2026

PoP end

$162K

Obligated

$162K

Potential

541380

NAICS

Q301

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Bioivt, LLC — $90

Contract facts

Federal

Contract number36C24E25N0245

Also listed as36C24E-25-N-0245

Also listed as36C24E25D0036-36C24E25N0245

AgencyRpo East (36C24E)

Awarding officeRpo East (36C24E)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentBioivt, LLC

CAGE6ZB76

UEIL2BGKGC6LJW7

NAICS541380

No full NAICS 541380 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36C24E25D0036

Place of performanceWESTBURY NY

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startSep 28, 2025

PoP end (current)Sep 27, 2026

Obligated$162K

Current value$162K

Potential value$162K

PRE-TRIAL TESTING FOR ALZHEIMER'S DRUG is a federal award for Rpo East (36C24E) held by Bioivt, LLC. Estimated value $162K ($162K obligated). Current period of performance ends Sep 27, 2026. Place of performance: WESTBURY NY.

Recompete timing

Public

● Expiring in 20 days

Current PoP ends Sep 27, 2026 (20 days remaining). Agencies typically plan 12–18 months ahead — at 0.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Bioivt, LLC — $814K obligated across 24 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($814K) · all agencies

Department of Health and Human Services (HHS)$366K · 45%Department of Defense (DOD)$252K · 31%Department of Veterans Affairs (VA)$162K · 20%

Environmental Protection Agency (EPA)$34K · 4%

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24E25N0245?

36C24E25N0245 (Pre-trial testing for alzheimer's DRUG) is a Rpo East (36C24E) award with a potential value of $162K, currently held by Bioivt, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C24E-25-N-0245?

36C24E-25-N-0245 is the dashed form of PIID 36C24E25N0245 (Pre-trial testing for alzheimer's DRUG), held by Bioivt, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24E25N0245?

Rpo East (36C24E) awarded 36C24E25N0245 to Bioivt, LLC (potential $162K).

Who is the incumbent on 36C24E25N0245?

Bioivt, LLC is the incumbent with $814K across 24 related awards in SCOUT’s public footprint. The current period of performance ends Sep 27, 2026.

When does Bioivt, LLC’s 36C24E25N0245 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 27, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C24E25N0245 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Sep 22, 2025